Literature DB >> 6487510

Improved effect of tolbutamide when given before food in patients on long-term therapy.

A Samanta, G R Jones, A C Burden, I Shakir.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6487510      PMCID： PMC1463618          DOI： 10.1111/j.1365-2125.1984.tb02522.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

Review 1.  Sulfonylurea drugs: mechanism of antidiabetic action and therapeutic usefulness.

Authors:  H E Lebovitz; M N Feinglos
Journal:  Diabetes Care       Date:  1978 May-Jun       Impact factor: 19.112

2.  Improved effect of glibenclamide on administration before breakfast.

Authors:  G Sartor; I Lundquist; A Melander; B Scherstén; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

3.  Therapeutic review: harmony with drugs with food.

Authors:  C B Tuttle
Journal:  Can Med Assoc J       Date:  1982-05-15       Impact factor: 8.262

4.  Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects.

Authors:  E Wåhlin-Boll; A Melander; G Sartor; B Scherstén
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

5.  Influence of food and age on the single-dose kinetics and effects of tolbutamide and chlorpropamide.

Authors:  G Sartor; A Melander; B Scherstén; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1980-04       Impact factor: 2.953

Review 6.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546
  6 in total
  8 in total

1.  Pharmacokinetic and pharmacodynamic studies of glibenclamide in non-insulin dependent diabetes mellitus.

Authors:  S W Coppack; A F Lant; C S McIntosh; A V Rodgers
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

2.  The effects of ingestion time of gliclazide in relationship to meals on plasma glucose, insulin and C-peptide levels.

Authors:  J Batch; A Ma; D Bird; R Noble; B Charles; P Ravenscroft; D Cameron
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 3.  The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.

Authors:  R E Ferner; S Chaplin
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

4.  Effect of magnesium hydroxide on the absorption and efficacy of tolbutamide and chlorpropamide.

Authors:  K T Kivistö; P J Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 5.  Is there a concentration-effect relationship for sulphonylureas?

Authors:  A Melander; R Donnelly; T Rydberg
Journal:  Clin Pharmacokinet       Date:  1998-03       Impact factor: 6.447

Review 6.  Effects of food on clinical pharmacokinetics.

Authors:  B N Singh
Journal:  Clin Pharmacokinet       Date:  1999-09       Impact factor: 6.447

Review 7.  Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

Authors:  A Melander; P O Bitzén; O Faber; L Groop
Journal:  Drugs       Date:  1989-01       Impact factor: 9.546

8.  Insulinotropic effect of the non-steroidal compound STX in pancreatic β-cells.

Authors:  Ana B Ropero; Paloma Alonso-Magdalena; Sergi Soriano; Pablo Juan-Picó; Troy A Roepke; Martin J Kelly; Ángel Nadal
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.